Australia's Genetic Technologies Ltd. named Paul Kasian as chairman of the board, replacing Malcolm Brandon, who recently resigned.
Kasian has been on the molecular diagnostics company's board since Dec. 2013.
Genetic Technologies names chairman
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Australia's Genetic Technologies Ltd. named Paul Kasian as chairman of the board, replacing Malcolm Brandon, who recently resigned.
Kasian has been on the molecular diagnostics company's board since Dec. 2013.